Faricimab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB15303 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 35 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | pseudo-von Willebrand disease | KG + DL |
| 3 | Glanzmann thrombasthenia | KG + DL |
| 4 | drug-induced osteoporosis | KG + DL |
| 5 | esotropia | KG + DL |
| 6 | severe nonproliferative diabetic retinopathy | KG + DL |
| 7 | HER2 positive breast carcinoma | KG + DL |
| 8 | diabetic retinopathy | KG + DL |
| 9 | respiratory syncytial virus infectious disease | KG + DL |
| 10 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 11 | breast tumor luminal A or B | KG + DL |
| 12 | progesterone-receptor positive breast cancer | KG + DL |
| 13 | normal breast-like subtype of breast carcinoma | KG + DL |
| 14 | progesterone-receptor negative breast cancer | KG + DL |
| 15 | progressive multiple sclerosis | KG + DL |
| 16 | diabetic cataract | KG + DL |
| 17 | non-syndromic esophageal malformation | KG + DL |
| 18 | senile cataract | KG + DL |
| 19 | nuclear senile cataract | KG + DL |
| 20 | cortical cataract | KG + DL |
| 21 | craniostenosis cataract | KG + DL |
| 22 | tetanic cataract | KG + DL |
| 23 | immature cataract | KG + DL |
| 24 | diabetes mellitus type 2 associated cataract | KG + DL |
| 25 | mature cataract | KG + DL |
| 26 | autosomal dominant macrothrombocytopenia | KG + DL |
| 27 | Scott syndrome | KG + DL |
| 28 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 29 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 30 | chromhidrosis | KG + DL |
| 31 | platelet-type bleeding disorder | KG + DL |
| 32 | anemia of prematurity | KG + DL |
| 33 | malignant cutaneous granular cell skin tumor | KG + DL |
| 34 | ectomesenchymoma | KG + DL |
| 35 | filariasis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.